Suppr超能文献

伊朗在预防走私和假冒伪劣卫生用品方面面临的挑战。

The challenges associated with the prevention of smuggling and counterfeiting health goods in Iran.

机构信息

Department of Health Management, Policy, and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Department of Global Health & Public Policy, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

BMC Public Health. 2024 Jun 11;24(1):1564. doi: 10.1186/s12889-024-18637-0.

Abstract

BACKGROUND

Smuggling health goods given the importance and critical nature of health services should be undeniably addressed and controlled by all countries. This issue is especially more widespread in developing countries with more damaging consequences. This paper therefore aims to identify and analyze the challenges of preventing smuggling of health goods in Iran.

METHOD

Within this qualitative study, we conducted face-to-face, semi-structured interviews with 30 purposefully recruited key informants and stakeholders in the detection, prevention, and combating of health goods smuggling. Each interview was analyzed thematically, using an inductive approach to generate codes, then categorized and presented in the form of main themes and sub-themes. Maxqda 11 assisted in coding, analysis, and data management.

RESULTS

Three main themes emerged representing the challenges of prevention of smuggling in Iran in the areas of anti-smuggling policy development, including categories of inefficient policy and plan, and failure to reach agenda; policy implementation; categorized into actors, resources and instruments, and implementation guarantee; and finally monitoring and evaluation; including, procedures and practices, and the role of surveyors.

CONCLUSION

Prevention of smuggling health goods proves to be a highly complex, challenging, and multi-faceted practice. Therefore, strengthening policy-making, regulatory frameworks, and facilitation functions about smuggling, counterfeiting, and corruption should be promoted in parallel.

摘要

背景

鉴于卫生服务的重要性和关键性质,走私卫生用品无疑应受到所有国家的关注和控制。在发展中国家,这一问题更为普遍,其后果更为严重。因此,本文旨在确定和分析伊朗在预防卫生用品走私方面所面临的挑战。

方法

在这项定性研究中,我们对 30 名有目的地招募的、在卫生用品走私检测、预防和打击方面的关键信息者和利益攸关方进行了面对面的半结构式访谈。采用归纳法对每个访谈进行主题分析,生成代码,然后归类为主要主题和子主题。Maxqda 11 用于辅助编码、分析和数据管理。

结果

出现了三个主要主题,代表了伊朗在反走私政策发展方面预防走私的挑战,包括分类为政策效率低下和计划失败,以及未能达到议程;政策执行;分为行为者、资源和手段以及执行保障;最后是监测和评估;包括程序和实践以及检查员的作用。

结论

预防卫生用品走私被证明是一项高度复杂、具有挑战性和多方面的实践。因此,应同时加强打击走私、假冒和腐败的决策制定、监管框架和便利化功能。

相似文献

1
The challenges associated with the prevention of smuggling and counterfeiting health goods in Iran.
BMC Public Health. 2024 Jun 11;24(1):1564. doi: 10.1186/s12889-024-18637-0.
2
Economic barriers to prevent the smuggling of health goods in Iran.
BMJ Glob Health. 2024 Jun 5;9(6):e015090. doi: 10.1136/bmjgh-2024-015090.
4
Exploring policy processes against microbial threats in Iran: a qualitative policy analysis.
BMJ Open. 2025 Jan 4;15(1):e087868. doi: 10.1136/bmjopen-2024-087868.
6
Oral health policymaking challenges in Iran: a qualitative approach.
BMC Oral Health. 2020 Jun 1;20(1):158. doi: 10.1186/s12903-020-01148-w.
7
Challenges in adopting health technology assessment for evidence-based policy in Iran: a qualitative study.
J Health Popul Nutr. 2025 Apr 23;44(1):134. doi: 10.1186/s41043-025-00887-2.
8
Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.
Health Res Policy Syst. 2021 Dec 23;19(1):150. doi: 10.1186/s12961-021-00762-6.

引用本文的文献

1
Actor-network and stakeholder analysis in preventing health goods smuggling in Iran.
Global Health. 2025 Sep 1;21(1):52. doi: 10.1186/s12992-025-01147-y.

本文引用的文献

1
CRIMINAL OFFENCES RELATED TO ILLICIT TRAFFICKING IN FALSIFIED MEDICINES: INVESTIGATION PROBLEMS.
Wiad Lek. 2023;76(5 pt 1):992-1000. doi: 10.36740/WLek202305116.
2
Implementing pharmaceutical track-and-trace systems: a realist review.
BMJ Glob Health. 2021 May;6(Suppl 3). doi: 10.1136/bmjgh-2020-003755.
4
5
Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level.
J Egypt Public Health Assoc. 2021 Jan 13;96(1):1. doi: 10.1186/s42506-020-00062-x.
7
What Makes a National Pharmaceutical Track and Trace System Succeed? Lessons From Turkey.
Glob Health Sci Pract. 2020 Sep 30;8(3):431-441. doi: 10.9745/GHSP-D-20-00084.
8
How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?
Am J Trop Med Hyg. 2020 Oct;103(4):1360-1363. doi: 10.4269/ajtmh.20-0903.
9
Counterfeit drugs and medical devices in developing countries.
Res Rep Trop Med. 2014 Apr 24;5:11-22. doi: 10.2147/RRTM.S39354. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验